Sortcell Analytica, an exciting spin-off from the University of Navarra, is at the forefront of innovation in the field of liquid biopsy. After five years of dedication and progress at the Center for Applied Medical Research (CIMA), we have brought Sortcell Analytica to life with the aim of bringing to market our microfluidic technologies for the isolation of circulating tumor cells (CTCs) from peripheral blood samples.
Sortcell Analytica enables personalized cancer treatment by analyzing a patient’s peripheral blood sample. Its product-based solution facilitates repeated intact cell testing in a simple, effective and affordable manner. Aiming to lead in non-invasive cell-based applications, Sortcell Analytica strives to offer simpler, faster and more accurate diagnostic and therapeutic approaches in the medical field.